Growth Metrics

Bio-Techne (TECH) Free Cash Flow (2016 - 2026)

Bio-Techne has reported Free Cash Flow over the past 17 years, most recently at $76.5 million for Q4 2025.

  • For Q4 2025, Free Cash Flow fell 1.34% year-over-year to $76.5 million; the TTM value through Dec 2025 reached $223.0 million, down 12.3%, while the annual FY2025 figure was $256.6 million, 8.66% up from the prior year.
  • Free Cash Flow for Q4 2025 was $76.5 million at Bio-Techne, up from $22.2 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $110.7 million in Q2 2021 and troughed at $22.2 million in Q3 2025.
  • A 5-year average of $63.1 million and a median of $61.3 million in 2021 define the central range for Free Cash Flow.
  • Biggest five-year swings in Free Cash Flow: soared 303.76% in 2021 and later tumbled 59.39% in 2025.
  • Year by year, Free Cash Flow stood at $90.8 million in 2021, then crashed by 35.84% to $58.3 million in 2022, then increased by 17.12% to $68.3 million in 2023, then increased by 13.59% to $77.5 million in 2024, then dropped by 1.34% to $76.5 million in 2025.
  • Business Quant data shows Free Cash Flow for TECH at $76.5 million in Q4 2025, $22.2 million in Q3 2025, and $93.3 million in Q2 2025.